Eton Pharmaceuticals Inc (ETON) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $56.15 (-1.61%), Market cap $0.90B, 52-week low–high $13.50 ~ $32.89.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700
Financial statements, price targets, institutional (13F) holdings and related news for Eton Pharmaceuticals Inc are updated in real time on BlackAll Trade.
Eton Pharmaceuticals Inc trades at $56.15 (-1.61%). Real-time quotes and charts are available on BlackAll Trade.
Eton Pharmaceuticals Inc has a market cap of about $0.90B.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of